口服荷尔蒙避孕药和女性心血管风险
Sukhwinder K Bhullar1, Inna Rabinovich-Nikitin1, Lorrie A Kirshenbaum1,2
1The Institute of Cardiovascular Sciences, St. Boniface Hospital Albrechtsen Research Centre, Department of Physiology and Pathophysiology, Rady College of Medicine, Max Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
Canadian journal of physiology and pharmacology
|May 23, 2024
概括
妇女使用口服激素避孕药 (OHC) 与心血管疾病风险有复杂的关系. 目前正在进行研究,以澄清OHC是否增加或减少心脏病等疾病的风险.
科学领域:
- 心血管健康 心血管健康
- 生殖内分泌学 生殖内分泌学
背景情况:
- 口服激素避孕药 (OHC) 广泛用于预防怀孕和治疗妇科疾病.
- 有关OHC与心血管疾病 (CVD) (如高血压和血栓形成) 的潜在联系存在担忧.
- 矛盾的证据表明,OHC也可能提供心脏保护作用,助长了正在进行的辩论.
研究的目的:
- 审查目前关于口服激素避孕药使用与女性心血管疾病风险之间的关联的证据.
- 综合了与OHC相关的CVD风险增加和潜在降低的发现.
主要方法:
- 系统审查最近的科学文献.
- 对调查女性使用OHC用于避孕或其他医疗原因的心血管结果的研究分析.
主要成果:
- 关于OHC和心血管疾病风险的证据仍然不一致和有争议.
- 虽然年轻健康女性的风险较低,但一些研究表明,生育年龄的女性心血管疾病风险略高.
- 长期使用OHC的潜在心脏保护作用也已报告.
结论:
- 由于数据相互矛盾,OHC与心血管疾病风险之间的关系需要进一步调查.
- 了解这些风险对于关于OHC使用的知情决策至关重要.
- 需要继续进行研究以澄清OHCs对心血管的净影响.
相关概念视频
Birth Control Methods
232
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
232
Hormonal Regulation of the Menstrual Cycle
345
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
345
Hormonal Regulation of Blood Pressure
2.6K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.6K
Hormonal Control of the Ovarian Cycle
474
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
474
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
728
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
728
Adrenergic Antagonists: ɑ and β-Receptor Blockers
434
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
434


